home / stock / gblx / gblx quote
Last: | $0.00775 |
---|---|
Change Percent: | 12.5% |
Open: | $0.007 |
Close: | $0.00775 |
High: | $0.00775 |
Low: | $0.007 |
Volume: | 1,000 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.00775 | $0.007 | $0.00775 | $0.00775 | $0.007 | 1,000 | 07-19-2024 |
$0.008 | $0.008 | $0.008 | $0.008375 | $0.008 | 156,585 | 07-18-2024 |
$0.008 | $0.00825 | $0.008 | $0.0085 | $0.008 | 1,300 | 07-17-2024 |
$0.00835 | $0.0066 | $0.00835 | $0.0087 | $0.0066 | 29,886 | 07-16-2024 |
$0.0087 | $0.0089 | $0.0087 | $0.0089 | $0.007 | 174,547 | 07-15-2024 |
$0.0083 | $0.0066 | $0.0083 | $0.0089 | $0.0066 | 62,643 | 07-12-2024 |
$0.00775 | $0.0092 | $0.00775 | $0.0098 | $0.0072 | 56,300 | 07-11-2024 |
$0.00955 | $0.007 | $0.00955 | $0.0099 | $0.007 | 141,747 | 07-10-2024 |
$0.00705 | $0.007 | $0.00705 | $0.00874 | $0.007 | 15,457 | 07-09-2024 |
$0.0077 | $0.00845 | $0.0077 | $0.00845 | $0.007 | 12,251 | 07-08-2024 |
$0.00795 | $0.008 | $0.00795 | $0.0099 | $0.00795 | 88,733 | 07-05-2024 |
$0.008 | $0.00645 | $0.008 | $0.0099 | $0.0065 | 51,290 | 07-04-2024 |
$0.008 | $0.00645 | $0.008 | $0.0099 | $0.00645 | 51,290 | 07-03-2024 |
$0.009 | $0.0065 | $0.009 | $0.009 | $0.0065 | 169,925 | 07-02-2024 |
$0.00752 | $0.00995 | $0.00752 | $0.00995 | $0.0065 | 62,647 | 07-01-2024 |
$0.00815 | $0.0064 | $0.00815 | $0.00815 | $0.0063 | 350,800 | 06-28-2024 |
$0.00784 | $0.0062 | $0.00784 | $0.0098 | $0.0062 | 58,544 | 06-27-2024 |
$0.0078 | $0.0062 | $0.0078 | $0.008 | $0.0062 | 12,894 | 06-26-2024 |
$0.0076 | $0.0066 | $0.0076 | $0.0082 | $0.0062 | 376,462 | 06-25-2024 |
$0.008 | $0.0098 | $0.008 | $0.01325 | $0.0061 | 484,096 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infect...
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which...
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selec...